Background Studies on microorganisms in a large cohort of patients with congenital heart disease (CHD) and infective endocarditis (IE) are rare. Using a nationwide survey, the relationship between causative microorganisms and clinical profiles in patients with CHD and IE was investigated.
nfective endocarditis (IE) still has high mortality and is associated with serious complications in patients with congenital heart disease (CHD), despite of advances in antimicrobial treatment. 1 An increased incidence of staphylococcal IE, especially that caused by methicillinresistant Staphylococcus aureus (MRSA) in children with CHD, has been reported. 2 The causative organism and antimicrobial treatment modify the clinical course and prognosis of IE in patients with CHD, but data from a large cohort are scarce. The present study used a large clinical database to determine the relationship between causative organisms and clinical profile/outcome of patients with CHD and IE in order to provide a basis for selecting the appropriate antibiotics for prevention and management of IE in pediatric and adult patients with CHD, as well as establishing proper guidelines for management.
Methods
Members of the Japanese Society of Pediatrics Cardiology and Cardiac Surgery in 66 institutions registered 239 pediatric and adult patients with CHD and IE diagnosed by clinical, echocardiographic and microbiologic findings during a 5-year period (1997) (1998) (1999) (2000) (2001) . The causative organism was identified in 201 patients, CHD was identified in 188 patients, and 13 pediatric patients with no detectable cardiac disease were excluded from the study. The relationships between causative microorganisms and clinical profile/outcome were analyzed in the 188 patients, who comprised 107 males and 81 females, with an age range from 14 days to 63 years (mean, 15.1±14.3 years; pediatric patients (n= 113), mean age, 6.2±4.9 years and adult patients (n=75), mean age 28.4±13.4). The data included causative organism, age, diagnosis of CHD, surgical history, source of infection, complications and mortality. There were 73 patients (38.8%) with cyanotic CHD, which included tetralogy of Fallot (TOF) in 34 (non-repaired: 17), double outlet right ventricle (DORV) in 14 (non-repaired: 9), single ventricle (heterotaxia) in 14 (non-repaired: 13), complete transposition of the great arteries (TGA) in 8 (non-repaired: 1), truncus arteriosus communis in 2 (non-repaired: 0), and hypoplastic left heart syndrome in 1 (non-repaired: 1). There were 109 patients (58.0%) with acyanotic CHD, which included ventricular septal defect (VSD) in 69 (nonrepaired: 57), mitral stenosis/regurgitation in 14 (non-re-I paired: 12), aortic stenosis/regurgitation in 8 (non-repaired: 5), coarctation of the aorta in 5 (non-repaired: 1), congenitally corrected TGA in 4 (non-repaired: 1), atrioventricular septal defect in 3 (non-repaired: 2), atrial septal defect (ASD) in 2 (non-repaired: 0), patent ductus arteriosus in 2 (non-repaired: 2), sinus of Valsalva aneurysm in 1 (non-repaired: 0), and Ebstein's anomaly 1 (non-repaired: 0). Two patients with ASD had an infected ASD patch during the postoperative period.
Age-Related Subgroups
For analysis of relation between age distribution and causative organisms, we divided the 188 patients into 5 subgroups based on differences in dental development: (1) neonates or infants, (2) 1-5 years, (3) 6-11 years, (4) 12-15 years, and (5) 16 years or older.
Statistical Analysis
Statistical analysis was performed with the software StatView, SAS Institute Inc (Cary, NC, USA). Numerical data are expressed as mean ± SD and either range or number. Discrete variables were analyzed by chi-square test. Continuous data were analyzed across the groups by Kruskal-Wallis test and when significant differences were found (p<0.05), pair-wise comparisons were performed using a two-sample t-test. A p-value <0.05 was considered significant. If a survey question was unanswered or the answer was unclear, those data were not counted. 
Results
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Relationship Between Diagnosis of CHD and Causative Microorganisms (Table 3)
The main causes of cyanotic CHD were TOF, DORV and heterotaxia, whereas VSD was the main cause of acyanotic CHD. In 13 of 14 (92.9%) cyanotic patients with heterotaxia, and in 57 of 69 (82.6%) acyanotic patients with VSD, IE developed in the case of non-repair or palliative surgery. In patients with cyanotic CHD, Staphylococcus species (32/68, 47.1%) were more frequent than Streptococcus species (28/94, 29.8%) (p<0.05), whereas in patients with acyanotic CHD, Streptococcus species (64/94, 68.1%) were more frequent (33/68, 48.5%) (p<0.05).
Source of Infection (Table 4)
The likely source of infection was identified in 59 patients (31.4%). The preceding factor of IE was determined in 28 of 94 patients with streptococcal IE (dental procedure (17/28, 60.7%); pneumonia (4/28, 14.3%)), and in 21 of 68 of patients with staphylococcal IE (cardiac surgery (7/21, 33.3%); dental procedure (3/21, 14.3%); atopic dermatitis (2/21, 9.5%)).
Cardiac Surgery and Causative Microorganisms (Table 5)
Streptococcus species were isolated in 52 of 84 patients (61.9%) without previous cardiac surgery and Staphylococcus species in 27 (32.1%). IE developed in 101 patients with previous cardiac surgery, including 38 with palliative surgery, of whom 16 (15.8%) developed IE perioperatively. (Table 6) Atrioventricular valves were the most commonly affected sites. The tricuspid valve was affected in 31 patients (16.5%) and the mitral valve in 30 patients (16.0%). In 5 of these 61 patients, 2 or 3 valves were infected, and 3 of 85 infected valves (3.5%) from 79 patients were prosthetic valves. The incidence of infected artificial materials such as conduits and patches was high (10/68, 14.7%) in staphylococcal IE compared with streptococcal IE (2/94, 2.1%) (p<0.05). 
Site of Infection and Causative Microorganisms
Complications and Causative Microorganisms (Table 7)
Complications were common (126/188=67.0%) and there was no significant difference in the incidence of complications among the different causative species. The incidence of vegetations was very low (1/9, 11.1%) with IE caused by Haemophilus species compared with the other species (p<0.05).
Fatal IE (Table 8)
Twenty patients (10.6%) died of IE at a mean age of 10.5 years (2 months to 25 years). Mortality was highest in patients less than 1 year of age (5/16, 31.3%) compared with the other subgroups; 7.7% (3/39) in 1-5 years, 8.1% (3/37) in 6-11 years, 14.3% (3/21) in 12-15 years and 8.0% (6/75) in 16 years or older. Fourteen deaths were in patients (70.0%) who had undergone cardiac surgery, 11 of whom were given prophylactic antibiotics before the onset of IE. S. aureus was isolated from 11 of the 20 dead patients (55.0%) including 7 with MRSA, whereas Streptococcus mitis was the causative pathogen only in 3 of the fatal cases (15.0%). The overall mortality was higher for S. aureus (11/57, 19 .3%) than for the Streptococcus species (5/94, 5.3%, p<0.05). Although Candida and Pseudomonas species were rare, the mortality was high for both: Candida (2/5, 40.0%) and Pseudomonas (2/4, 50.0%). Candida species were primarily isolated from fatal cases with longterm intravenous antibiotic treatment.
Discussion
The causative microorganism significantly influences the clinical profile and course in CHD patients with IE. The present results will help in matching the causative organism with the clinical manifestation, and therefore in the selection of the correct antibiotics for prevention and management.
Microorganisms
In this study, Streptococcus and Staphylococcus species were the most commonly isolated of the causative organisms for IE, and the Streptococcus mitis group was the most frequent. Nakatani et al in Japan recently described the annual trend of IE in 817 adults with various cardiovascular diseases, including 9.1% who had CHD, and they isolated 697 microorganisms (85%), with 50% Streptococcus species and 32% Staphylococcus species. 5 In a UK survey of IE in adults with cardiovascular disease, including 27% with CHD, conducted between 1987 and 1996, Streptococcus species comprised 49% and Staphylococcus species comprised 26%. 6 In contrast, a US study reported that Staphylococcus species caused 50% of all episodes of IE in pediatric patients, followed by Streptococcus species in 22%. 1 The results of the present study are similar to those in previous reports from Japan and the UK studies, but different from the US study, and the discrepancy may be related to patient age, type of CHD and type of preventive measures. The incidence of staphylococcal IE was higher in patients with cyanotic CHD than in those with acyanotic CHD. In the US study, 51% of the CHD patients were cyanotic CHD vs 39% in our study. There was a significant difference between staphylococcal IE and streptococcal IE in mean age: 12.8 and 17.6 years, respectively. In patients under 1 year of age, the prevalence of staphylococcal IE was significantly higher than that of streptococcal IE (16.2% vs 2.1%). Furthermore, 81.8% of the S. aureus strains cultured from these patients were MRSA.
Predisposing Factors for IE
In this study, the leading predisposing risk factor was dental procedures. The American Heart Association recommends antibiotic prophylaxis for dental procedures in patients with most types of CHD, excluding simple ASD and repaired simple CHD without postoperative residua beyond 6 months postoperatively. 7 In our study, 53.7% of patients with CHD had undergone cardiac surgery, and perioperative IE was observed in 8.5%, an incidence similar to previous reports. 1, 10 Cardiac surgery was the second most frequent predisposing risk factor, and Staphylococcus species were the major pathogen. Atopic dermatitis was a frequent predisposing risk factor for staphylococcal IE. Although there are only a few case reports of IE associated with atopic dermatitis, 11,12 the incidence of atopic dermatitis in Japan is rapidly increasing, a warning that prophylactic measures should be taken to prevent IE.
Infected Sites
The infected valve differed markedly between IE patients with CHD and without CHD. The aortic valve was the most commonly affected site in IE patients without CHD, 6 whereas the tricuspid and mitral valves were the most common affected sites in those with CHD. The incidence of prosthetic valve IE in patients with CHD was lower than in the adult cohort, 13 and infection of artificial materials, such as conduits and patches, mainly occurred with staphylococcal IE.
Morbidity and Mortality
Despite remarkable developments and improvements in the treatment of IE, morbidity and mortality remain high, 14, 15 as high as 10.0% in the present study. IE caused by MRSA had the highest mortality, followed by Candida and Pseudomonas, even though the latter are rare pathogens. These organisms are typically hospital-acquired, nosocomial pathogens that have been increasingly observed in patients with IE since the 1980s. S. aureus has been recognized as an important pathogen since the 1970s, and recently MRSA and coagulase-negative staphylococci have increased in prevalence. 13, 16 There has also been an increased incidence of fungal endocarditis, 17 reflecting the longer duration of broad-spectrum antimicrobial therapy in seriously ill patients. Novel therapies against nosocomial pathogens are needed to improve patient outcome.
Conclusions
The causative microorganism is significantly related to the clinical profile and outcome of IE. Staphylococcal IE is frequent in perioperative patients less than 1 year of age, in patients with cyanotic CHD, and in older patients with atopic dermatitis, whereas streptococcal IE is frequent in patients aged 16 years or more, with acyanotic CHD and without previous cardiac surgery.
